CORTICOSTERONE RESPONSE TO THE SEROTONERGIC AGONIST D-FENFLURAMINE MAY BE INDEPENDENT FROM CORTICOTROPIN-RELEASING FACTOR (CRF)

被引:8
作者
BAUDRIE, V
OLIVER, C
CHAOULOFF, F
机构
[1] CHU NECKER ENFANTS MALAD,PHARMACOL LAB,NEUROPHARMACOL GRP,CNRS,URA 1482,156 RUE VAUGIRARD,F-75015 PARIS,FRANCE
[2] FAC MED NORD,INSERM,U297,NEUROENDOCRINOL EXPTL LAB,MARSEILLE,FRANCE
关键词
CORTICOTROPIN-RELEASING FACTOR; CORTICOSTERONE; GLUCOSE; D-FENFLURAMINE; SEROTONIN; ETHER STRESS;
D O I
10.1016/0304-3940(93)90454-S
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
This study was designed to assess the involvement of corticotropin-releasing factor (CRF) in the corticosterone response to the acute administration of the serotonergic indirect agonist D-fenfluramine in the rat. In addition to plasma corticosterone. D-fenfluramine-induced hyperglycemia (which is independent from the hypothalamo-pituitary-adrenal axis) was also analyzed. Acute i.v. injection of sheep anti-CRF antiserum (15 min beforehand) markedly diminished ether stress-induced corticosterone release (but not ether stress-induced increases in plasma glucose levels), thereby indicating that passive immunization was efficient. Acute administration of D-fenfluramine (3 mg/kg i.v.) increased plasma corticosterone and glucose levels to similar extents in control rats (i.e. injected with normal sheep serum) and in anti-CRF antiserum-injected rats. These results indicate that. under our experimental conditionS, D-fenfluramine-induced corticosterone elevation is of peripheral origin (through pituitary and/or adrenocortical pathways).
引用
收藏
页码:121 / 124
页数:4
相关论文
共 20 条
[1]  
Broqua P, 1992, Eur Neuropsychopharmacol, V2, P115, DOI 10.1016/0924-977X(92)90020-9
[2]  
CHAOULOFF F, 1992, J PHARMACOL EXP THER, V260, P1008
[3]   PHYSIOPHARMACOLOGICAL INTERACTIONS BETWEEN STRESS HORMONES AND CENTRAL SEROTONERGIC SYSTEMS [J].
CHAOULOFF, F .
BRAIN RESEARCH REVIEWS, 1993, 18 (01) :1-32
[4]   NEW PERIPHERAL ANTAGONISTS OF 5-HYDROXYTRYPTAMINE [J].
COPP, FC ;
GREEN, AF ;
HODSON, HF ;
RANDALL, AW ;
SIM, MF .
NATURE, 1967, 214 (5084) :200-&
[5]   THE NOVEL ANTIDEPRESSANT, TIANEPTINE, REDUCES STRESS-EVOKED STIMULATION OF THE HYPOTHALAMO-PITUITARY-ADRENAL AXIS [J].
DELBENDE, C ;
CONTESSE, V ;
MOCAER, E ;
KAMOUN, A ;
VAUDRY, H .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 202 (03) :391-396
[6]   DEPLETION OF HYPOTHALAMIC NOREPINEPHRINE AND SEROTONIN ENHANCES THE DEXAMETHASONE NEGATIVE FEEDBACK EFFECT ON ADRENOCORTICAL SECRETION [J].
FELDMAN, S ;
WEIDENFELD, J .
PSYCHONEUROENDOCRINOLOGY, 1991, 16 (05) :397-405
[8]   SEROTONERGIC STIMULATION OF PITUITARY-ADRENOCORTICAL FUNCTION IN RATS [J].
FULLER, RW .
NEUROENDOCRINOLOGY, 1981, 32 (02) :118-127
[9]   NEUROCHEMICAL MECHANISM OF ACTION OF DRUGS WHICH MODIFY FEEDING VIA THE SEROTONINERGIC SYSTEM [J].
GARATTINI, S ;
MENNINI, T ;
BENDOTTI, C ;
INVERNIZZI, R ;
SAMANIN, R .
APPETITE, 1986, 7 :15-38
[10]   EFFECT OF THE SEROTONIN REUPTAKE INHIBITOR FLUOXETINE ON CORTICOTROPIN-RELEASING FACTOR AND VASOPRESSIN SECRETION INTO HYPOPHYSEAL PORTAL BLOOD [J].
GIBBS, DM ;
VALE, W .
BRAIN RESEARCH, 1983, 280 (01) :176-179